Kokilaben Dhirubhai Ambani Hospital

Kokilaben Dhirubhai Ambani Hospital (KDAH) is one of India's most advanced quaternary care hospitals, established in 2009 in Andheri West, Mumbai, by the Dhirubhai Ambani Foundation. Named in memory of the late Dhirubhai Ambani, founder of Reliance Industries, the hospital embodies the Ambani family's vision of world-class healthcare for India.

The hospital is Joint Commission International (JCI) accredited, placing it among an elite group of Indian hospitals meeting internationally recognised standards for patient safety and quality of care. This accreditation is a key distinguishing feature that gives international patients confidence in the hospital's quality benchmarks.

KDAH is particularly renowned for robotic surgery — it was among the first hospitals in India to establish a comprehensive robotic surgery programme across multiple specialties. The hospital's Cancer Centre, Heart Institute, Neurosciences department, and Institute of Musculoskeletal Disorders represent centres of excellence within its broad multi-specialty scope.

With approximately 750 beds across a modern campus, the hospital attracts complex cases from across India and international patients from over 70 countries. Senior consultants include India's foremost specialists who bring expertise in cutting-edge surgical and medical techniques.

The hospital's location in Andheri West places it close to Mumbai's domestic and international airports, making it highly accessible for both domestic referrals and international medical tourists. Dedicated international patient services, multiple language capabilities, and a patient-centred philosophy reinforce its position as a leading destination for medical travel to India.

Kokilaben Dhirubhai Ambani Hospital offers comprehensive clinical services across major medical and surgical specialties with dedicated institutes and centres:

Cancer Centre: Comprehensive oncology including surgical oncology with robotic tumour surgery, medical oncology (chemotherapy, targeted therapy, immunotherapy), radiation oncology with IMRT/IGRT, bone marrow transplantation, and tumour board multidisciplinary reviews.

Heart Institute: Interventional cardiology (complex coronary angioplasty, TAVR, MitraClip), electrophysiology and ablation, cardiac surgery (CABG, valve repair/replacement, LVAD), advanced cardiac imaging (cardiac MRI, cardiac CT, 3D echo).

Neurosciences: Neurology (stroke with thrombolysis, epilepsy, movement disorders) and neurosurgery (brain tumours, AVM, aneurysm, spine). Gamma Knife radiosurgery and neuronavigation available.

Robotic Surgery: One of India's most advanced robotic surgery programmes using da Vinci surgical systems for urology, oncology, gynaecology, and thoracic surgery.

Institute of Musculoskeletal Disorders: Joint replacement (hip, knee, shoulder), spine surgery, sports medicine, and arthroscopy.

Renal Sciences: Nephrology, haemodialysis, and kidney transplantation.

Digestive and Liver Diseases: Advanced endoscopy (EUS, ERCP), hepatology, and GI surgery including liver transplantation.

Neonatology and Paediatrics: Level III NICU, paediatric surgery, paediatric cardiology.

Women and Child Health: High-risk obstetrics, reproductive medicine, laparoscopic gynaecology.

Critical Care: State-of-the-art ICU with 24-hour intensivist coverage.

Kokilaben Dhirubhai Ambani Hospital is equipped with India's most advanced medical technology across its 750-bed campus.

The robotic surgery programme uses da Vinci robotic surgical systems enabling minimally invasive procedures with greater precision, reduced blood loss, and faster recovery for urological, oncological, gynaecological, and thoracic cases.

Neuroimaging includes 3T MRI with advanced neurological protocols, 256-slice CT scanner, digital subtraction angiography (DSA), and intraoperative MRI for neurosurgery. Gamma Knife radiosurgery provides non-invasive stereotactic treatment for brain lesions. Neuronavigation guides complex brain and spine surgeries.

The cardiac catheterisation laboratories support complex coronary interventions, structural heart procedures (TAVR for aortic valve replacement without surgery, MitraClip for mitral valve repair), and electrophysiology ablations for complex arrhythmias. Cardiac MRI and cardiac CT provide advanced non-invasive cardiac imaging.

The Cancer Centre houses linear accelerators with IMRT, IGRT, and SBRT capabilities. PET-CT enables precise cancer staging. A bone marrow transplant unit with HEPA-filtered isolation rooms supports stem cell transplantation programmes.

A multi-organ ICU with over 100 beds provides critical care with invasive monitoring, mechanical ventilation, ECMO, and renal replacement therapy. Multiple laminar flow OTs support complex surgical specialties. An advanced pathology laboratory with molecular diagnostics, flow cytometry, and immunohistochemistry supports precision medicine. The blood bank maintains 24-hour availability.

Kokilaben Dhirubhai Ambani Hospital has a dedicated International Patient Services (IPS) centre serving patients from over 70 countries. JCI accreditation provides the quality assurance framework that international patients rely on when choosing a hospital abroad.

The IPS centre provides a comprehensive patient journey from first inquiry through post-discharge follow-up. Services include preliminary medical record review and treatment planning by senior specialists before the patient travels, visa support letter issuance, airport-to-hospital transfers, accommodation arrangement at the hospital's guest house or nearby hotels, insurance pre-authorisation, and telemedicine follow-up consultations after return home.

Interpreters and translators are available for major international languages including Arabic, Swahili, Russian, French, and other languages commonly needed by international patients. All medical documentation including discharge summaries, operative notes, and imaging reports are provided in English.

The hospital serves patients from the Middle East (UAE, Saudi Arabia, Oman, Kuwait), East Africa (Kenya, Tanzania, Uganda, Ethiopia), South Asia (Bangladesh, Nepal, Sri Lanka, Pakistan), Southeast Asia, and Western countries (UK, USA, Canada). Many international oncology, cardiac, and neurosurgery patients choose KDAH for the combination of JCI-accredited quality, advanced technology, and costs 40-70% below equivalent care in Western countries.

The hospital's location in Andheri West is approximately 5 km from both Mumbai's domestic and international terminals, making transfers rapid and convenient.

Kokilaben Dhirubhai Ambani Hospital holds Joint Commission International (JCI) accreditation — the global gold standard for hospital quality and patient safety. JCI accreditation requires demonstrating compliance with rigorous standards across patient care, safety, infection control, medication management, quality improvement, and governance, reassessed every three years.

In addition to JCI, the hospital is accredited by NABH (National Accreditation Board for Hospitals and Healthcare Providers) — India's national hospital quality certification body. Dual JCI and NABH accreditation represents the highest level of quality recognition for an Indian hospital.

The blood bank is NABH blood bank accredited and follows NBTC standards. The pathology laboratory is NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited. The radiation oncology department operates under AERB (Atomic Energy Regulatory Board) licence with comprehensive radiation safety and equipment QA programmes.

The robotic surgery programme follows the da Vinci system training and credentialling protocols of Intuitive Surgical. Organ transplantation (kidney, liver, bone marrow) programmes hold government authorisation under the Transplantation of Human Organs Act (THOA).

Senior consultants are India's top specialists, many holding international fellowships, professorships, and leadership roles in national and international medical societies. The hospital conducts academic activities including CME programmes and participates in national and international clinical research.